Teladoc Health (NYSE:TDOC) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Teladoc Health (NYSE:TDOC) released its earnings results on Thursday. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02), Briefing.com reports. The business had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the company earned ($0.37) earnings per share.

Teladoc Health Stock Down 1.5 %

Shares of TDOC stock traded down $0.20 during trading on Friday, reaching $13.13. The company’s stock had a trading volume of 3,886,735 shares, compared to its average volume of 4,749,148. The business has a fifty day moving average price of $15.17 and a 200-day moving average price of $17.80. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. The company has a market cap of $2.22 billion, a price-to-earnings ratio of -9.87 and a beta of 0.94. Teladoc Health has a one year low of $12.65 and a one year high of $30.41.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CTO Nikolaos P. Nanis sold 2,866 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $41,614.32. Following the transaction, the chief technology officer now directly owns 69,850 shares in the company, valued at $1,014,222. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the firm’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CTO Nikolaos P. Nanis sold 2,866 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $41,614.32. Following the completion of the sale, the chief technology officer now owns 69,850 shares in the company, valued at $1,014,222. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock valued at $2,038,251 over the last 90 days. 1.63% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

TDOC has been the subject of several research analyst reports. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Friday. Leerink Partnrs restated a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 price target for the company. SVB Leerink assumed coverage on shares of Teladoc Health in a research report on Monday, February 26th. They issued a “market perform” rating and a $17.00 price target for the company. Finally, Canaccord Genuity Group cut their target price on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Friday. Nine investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $21.21.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.